Adam M. Koppel's Insider Trades & SAST Disclosures
Adam M. Koppel's most recent trade in Foghorn Therapeutics Inc was a trade of 16,000 Stock Options (Right to buy) done . Disclosure was reported to the exchange on June 26, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Adam M. Koppel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Foghorn Therapeutics Inc | Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 16,000 | 16,000 | - | - | Stock Options (Right to buy) | |
| Cerevel Therapeutics Holdi... | Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,461 | 13,743 | - | - | Common Stock | |
| Solid Biosciences Inc | Koppel M. Adam | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 5.53 per share. | 11 Jan 2024 | 904,160 | 4,034,582 (8%) | 1% | 5.5 | 5,000,005 | Common Stock |
| Foghorn Therapeutics Inc | Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Cerevel Therapeutics Holdi... | Adam M. Koppel | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 07 Jun 2023 | 432,627 | 60,199,729 | - | 0 | Common Stock | |
| Cerevel Therapeutics Holdi... | Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 13,780 | 13,780 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,282 | 3,282 | - | - | Common Stock | |
| Solid Biosciences Inc | Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 2,666 | 2,666 | - | - | Director Stock Option (Right to Buy) | |
| Foghorn Therapeutics Inc | Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 16,000 | 16,000 | - | - | Stock Options (Right to buy) | |
| Cerevel Therapeutics Holdi... | Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 23,459 | 23,459 | - | - | Stock Option (Right to Buy) | |
| Foghorn Therapeutics Inc | Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2021 | 12,530 | 12,530 | - | - | Stock Option (right to buy) | |
| Cerevel Therapeutics Holdi... | Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 42,950 | 42,950 | - | - | Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 5.75 per share. | 23 Mar 2021 | 869,565 | 7,929,918 (17%) | 1% | 5.8 | 4,999,999 | Common Stock |
| Solid Biosciences Inc | Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 3.70 per share. | 10 Dec 2020 | 3,189,189 | 7,060,353 (15%) | 6% | 3.7 | 11,799,999 | Common Stock |
| Cerevel Therapeutics Holdi... | Adam M. Koppel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.30 per share. | 09 Nov 2020 | 332,293 | 60,632,356 | - | 10.3 | 3,422,618 | Common Stock |
| Cerevel Therapeutics Holdi... | Adam M. Koppel | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Oct 2020 | 49,961,943 | 50,300,063 | - | - | Common Stock | |
| Cerevel Therapeutics Holdi... | Adam M. Koppel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 27 Oct 2020 | 10,000,000 | 60,300,063 | - | 10 | 100,000,000 | Common Stock |
| Solid Biosciences Inc | Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 30,000 | 30,000 | - | - | Director Stock Option (Right To Buy) | |
| Solid Biosciences Inc | Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 10,000 | 10,000 | - | - | Director Stock Option (Right To Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges